Company: KROS
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001664710-25-000018
Chunk: 32

Company: Keros Therapeutics, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 7A
Chunk 32
---
 of Common Stock Certificate.S-1/A333-2372124.2April 1, 20204.3*Description of the Registrant’s Securities.10.1Form of Indemnity Agreement between the registrant and its directors and officers.S-1/A333-23721210.1April 1, 202010.2+2017 Stock Incentive Plan, as amended.S-1333-23721210.2March 16, 202010.3+Form of Stock Option Grant Notice and Option Agreement for the 2017 Stock Incentive Plan, as amended.S-1333-23721210.3March 16, 202010.4+2020 Equity Incentive Plan.S-1/A333-23721210.4April 1, 202010.5*+Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement for the 2020 Equity Incentive Plan.10.6+2020 Employee Stock Purchase Plan.S-1/A333-23721210.6April 1, 202010.7+Amended and Restated Non-Employee Director Compensation Policy10-Q001-3926410.1August 7, 202410.8+Offer Letter Agreement by and between the registrant and Jasbir Seehra, dated as of December 14, 2015.S-1333-23721210.7March 16, 2020

112

10.9#Exclusive Patent License Agreement by and between the registrant and The General Hospital Corporation, d/b/a Massachusetts General Hospital, or MGH, dated as of April 5, 2016, as amended by Amendment #1 by and between the registrant and The Brigham and Women’s Hospital, Inc. on May 12, 2017 and by Amendment #2 by and between the registrant and MGH on February 23, 2018.S-1333-23721210.10March 16, 202010.10#License Agreement by and between the registrant and Hansoh (Shanghai) Healthtech Co., Ltd., dated as of December 12, 2021, as amended by Amendment No. 1 by and between the registrant and Hansoh (Shanghai) Healthtech Co., Ltd., dated as of February 10, 2022.10-K001-3926410.10